As of January 2026 4D Molecular Therapeutics has a market cap of NZ$0.75 Billion. This makes 4D Molecular Therapeutics the world's 7428th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 21st, 2026 the market cap of 4D Molecular Therapeutics was reported to be: